Listed

Dianthus Therapeutics, Inc.

DNTHNasdaqCIK 1690585HealthcareFiscal year ends Dec 31

Reports and events: 154 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Dianthus Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2018-06-1906:17 ETS-1/ARegistration statement, amended0001193125-18-196227
2018-06-1807:01 ETS-1/ARegistration statement, amended0001193125-18-194979
2018-06-0807:03 ETS-1/ARegistration statement, amended0001193125-18-187319
2018-05-2416:14 ETS-1Registration statement0001193125-18-173570

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:49 ET. Listed shows no prices and gives no investment advice.